Resource Library

Whitepapers

Redefining BsAb development with structural innovation and enhanced manufacturability


Bispecific antibodies (bsAbs) play a unique role in reducing off-target effects, enhancing selectivity, and improving pharmacodynamics. Despite their therapuetic potential, the development of bsAbs can pose challenges in the purification process during manufacturing, such as mispairing during assembly. 


Through improved molecular design to promote correct chain pairing, optimized bioprocessing techniques, and advanced analytical methods to ensure high product purity and efficacy, Samsung Biologics’ S-KiH platform ensures bsAb manufacturability. S-KiH streamlines the bsAb manufacturing process, reducing costs and enhacing overall clinical viability. 


In combination with S-DUAL, S-KiH can accelerate the development of next-generation bsAb therapeutics, making them more accessible and scalable for diverse medical applications. Learn more in our latest whitepaper.


Bispecific antibodies (bsAbs) play a unique role in reducing off-target effects, enhancing selectivity, and improving pharmacodynamics. Despite their therapuetic potential, the development of bsAbs can pose challenges in the purification process during manufacturing, such as mispairing during assembly. 


Through improved molecular design to promote correct chain pairing, optimized bioprocessing techniques, and advanced analytical methods to ensure high product purity and efficacy, Samsung Biologics’ S-KiH platform ensures bsAb manufacturability. S-KiH streamlines the bsAb manufacturing process, reducing costs and enhacing overall clinical viability. 


In combination with S-DUAL, S-KiH can accelerate the development of next-generation bsAb therapeutics, making them more accessible and scalable for diverse medical applications. Learn more in our latest whitepaper.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION